Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bessemer Group Inc. boosted its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 37.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 315 shares of the medical instruments supplier’s stock after purchasing an additional 85 shares during […]
Citigroup upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a neutral rating to a buy rating in a report released on Monday, Marketbeat Ratings reports. They currently have $265.00 price target on the medical instruments supplier’s stock, down from their previous price target of $273.00. A number of other brokerages also recently commented on […]
Citigroup upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a neutral rating to a buy rating in a report released on Monday morning, MarketBeat Ratings reports. They currently have $265.00 price objective on the medical instruments supplier’s stock, down from their previous price objective of $273.00. PODD has been the subject of several other […]
Gateway Advisory LLC acquired a new stake in Insulet Co. (NASDAQ:PODD – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 549,887 shares of the medical instruments supplier’s stock, valued at approximately $550,000. Other large investors also recently bought […]
Equities researchers at StockNews.com began coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the medical instruments supplier’s stock. A number of other brokerages have also commented on PODD. Wells Fargo & Company cut their price target on Insulet […]